Mark G. Foletta, Director at DEXCOM INC (DXCM), sold 1,825 shares at $236.84 ($434K) on 2020-02-03, disclosed to the SEC on 2020-02-05.
Open-market sale of $434k DXCM by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $236.84 | 301 | $71K | 16.4% |
| 2 | $236.84 | 301 | $71K | 16.4% |
| 3 | $238.05 | 524 | $125K | 28.8% |
| 4 | $238.05 | 524 | $125K | 28.8% |
| 5 | $238.86 | 166 | $40K | 9.1% |
| 6 | $240.68 | 9 |
| $2K |
| 0.5% |
| Total | $237.74 avg | 1,825 | $434K | 100% |
| Filing → |
| DXCM | SELL | 2026-06-17 | $297K | — | Filing → |
| DXCM | SELL | 2025-08-18 | $430K | — | Filing → |
| DXCM | SELL | 2025-07-17 | $468K | — | Filing → |